FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating a thermal burn of the cornea. Ointment contains biologically active substance 6-methyl-3-(thietan-3-yl)uracil, wherein as an ointment base contains Vaseline and lanolin, taken in ratio 9:1. Components are used in claimed amounts.
EFFECT: use of the invention provides higher clinical effectiveness in thermal burns of the cornea.
1 cl, 4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC DRUG FILM WITH 6-METHYL-3-(THIETAN-3-YL)URACIL, HAVING WOUND-HEALING EFFECT | 2020 |
|
RU2740923C1 |
BURN OINTMENT | 2013 |
|
RU2523551C1 |
OPHTHALMIC OINTMENT | 2007 |
|
RU2331408C1 |
OPHTHALMIC DRUG FILM WITH METHYLURACIL EXHIBITING WOUND HEALING EFFECT | 2020 |
|
RU2740924C1 |
USE OF N'-{1-[6-METHYL-3-(TIETANE-3-YL)-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL]PROPAN-2-YLIDENE} ISONICOTINOHYDRAZIDE AS MEANS THAT STIMULATE TISSUE REGENERATION | 2023 |
|
RU2813148C1 |
SUSPENDED METHYLURACIL FORMULATION | 1992 |
|
RU2007998C1 |
ANTIBACTERIAL DRUG IN FORM OF OINTMENT FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580631C1 |
PHARMACOLOGICALLY ACTIVE SUBSTANCE FOR OPHTHALMOLOGY | 2004 |
|
RU2272635C1 |
METHOD OF TREATING CORNEAL BURNS | 2021 |
|
RU2766298C2 |
METHOD FOR TREATMENT OF VASCULARIZED CORNEAL LEUKOMA RESULTING FROM EYE BURN INJURY | 2016 |
|
RU2635540C1 |
Authors
Dates
2019-11-07—Published
2019-07-19—Filed